This study evaluated the effect of restrictive filling pattern (RFP) on 5-year outcomes in patients following ST-segment elevation myocardial infarction (STEMI). A hundred STEMI patients treated either by rescue or primary percutaneous coronary intervention with an echocardiogram performed within 6 weeks of STEMI comprised the study group. Creatinine kinase (CK) and left ventricular ejection fraction were independent determinants of RFP, and RFP was an independent predictor of cardiac and all-cause mortality at median follow up of 5 years.
Percutaneous coronary intervention (PCI), for STsegment elevation myocardial infarction (STEMI), limits myocardial injury and reduces mortality; 1 however, myocardial damage from STEMI results in systolic and diastolic dysfunction (DD). Although elevated left ventricular (LV) end-diastolic pressure is a predictor of adverse outcome after STEMI, 2 its invasive nature precludes routine clinical use. Non-invasive estimates of diastolic function, particularly Doppler assessment of LV filling and, more recently, left atrial (LA) volume, have been reported to be predictors of outcome following myocardial infarction (MI). 3 Previous studies have reported the adverse impact of restrictive filling pattern (RFP) in STEMI patients treated by thrombolysis, demonstrating increased all-cause mortality. 4 The present study evaluated the impact of RFP on longer term outcomes in STEMI patients treated by PCI. We hypothesised that RFP would remain an independent predictor of longer term outcomes in STEMI patients treated by PCI.
A total of 107 consecutive STEMI patients from Liverpool Hospital, Sydney (January 2003-May 2010), underwent a transthoracic echocardiogram (TTE) (day 3-6 weeks), following STEMI. Patients were excluded for atrial fibrillation (n = 3), severe mitral regurgitation (n = 1) and poor echocardiographic images (n = 3). A total of 100 patients (78 males; mean age: 59 ± 11 years) comprised the study group, and was treated by rescue (n = 40) or primary (n = 60) PCI. All patients were clinically stable when the TTE was performed; none had an intra-aortic balloon pump, were on inotropes or in heart failure (HF). All participants had cardiac enzyme evaluation. The study protocol was approved by the Sydney South West Area Health Service ethics committee (QA2009/046).
A comprehensive echocardiogram was performed using commercial equipment (Phillips Sonos 7500, Philips Co, The Netherlands; GE Vivid 7, Horten, Norway) according to standard recommendations. 5 Transmitral flow was obtained from the apical four-chamber view using pulsed Doppler, and peak E and A velocities, E/A ratio, and deceleration time (DT) were measured. Pulsed tissue Doppler imaging (TDI) from the septal mitral annulus in early diastole (e') was evaluated when available (n = 59).
LV diastolic function was classified as normal, impaired relaxation, pseudo-normal and restrictive filling based on published criteria; 5 RFP was defined as E/A ratio >2 and/or DT <140 ms. 6 Patients (n = 10) with indeterminate diastolic grade (i.e. normal vs pseudo-normal filling) were reviewed using A-wave and pulmonary vein A-wave duration and e' velocity. Left ventricular ejection fraction (LVEF) 7 was measured using the modified biplane Simpson's method; biplane maximum LA volume was measured using the area-length method; and LV mass was calculated using the Penn method. 8 The latter two variables were indexed to body surface area.
Baseline demographic details, cardiac risk factors and discharge medications were obtained from patient records. Duration of ischaemia was measured from symptom onset to establishing TIMI-3 flow. Clinical outcomes, including cardiac death, all-cause death, HF hospitalisation, non-fatal MI, stroke and coronary revascularisation, were tracked for a median of 5 years, from hospital records and/or by telephone follow up from patients or their physicians. Major adverse coronary and cerebral events were a composite of HF, death, MI, stroke or revascularisation.
Analysis was performed using SPSS 19 (SPSS Inc., Chicago, IL, USA) and Stata 12 (StataCorp, College Station, TX, USA). All statistical tests were two-tailed and a P value <0.05 was deemed significant. Cumulative survival was constructed by Kaplan-Meier curves, and groups were compared with the log-rank test. A Cox regression analysis was performed for the primary endpoint; variables significant at the bivariate level (P < 0.05) or had clinical relevance were included in the model. Multivariate logistic regression analysis was performed to identify independent determinants of RFP.
The study cohort was stratified into restrictive (n = 24) and non-restrictive (n = 76) groups (Table 1) . A higher proportion of patients treated with rescue PCI had RFP (58% vs 34%, P = 0.035). Age, gender and cardiac risk factors were similar. A significantly higher percentage in the RFP group was discharged on loop diuretics and/or aldactone (46% vs 19%, P = 0.011). Higher levels of cardiac enzymes (TnT, CKMB and CK) were found in RFP patients (P < 0.05 in all). E/A ratio was higher in RFP patients (Table 1) . TDI septal e' velocity was reduced in the RFP group, but showed no significant difference. A significantly larger indexed LA volume and a lower LVEF was found in patients with RFP than non-RFP group (43.2 ± 18 vs 35.8 ± 11 mL/m 2 , P = 0.017, and 41.4 ± 11.5% vs 48.7 ± 8.7%, P = 0.001, respectively), whereas indexed LV mass was similar between the groups (Table 1) .
Kaplan-Meier analyses demonstrated that both cardiac (1% vs 21%, P < 0.001) and all-cause death (9% vs 38%, P = 0.003) were higher in RFP patients (Fig. S1 ). There was no significant difference for other end-points (Table S1 ). Cox regression analysis was performed to investigate the predictive values of clinical and echocardiographic indices on all-cause and cardiac death.
Variables included in the model were age, gender, PCI (rescue vs primary), infarct-related variables (TnT, CK, proximal LAD lesion and duration of ischaemia) and echocardiographic indices (LVEF, indexed LV mass and This study evaluated the impact of RFP on long-term outcomes in STEMI patients treated with PCI; RFP and age were independent predictors of cardiac and all-cause mortality. Restrictive filling was more prevalent in rescue PCI patients, those with higher cardiac biomarker levels, a larger LA volume and a reduced LVEF. On multivariate analysis, CK and LVEF were independent predictors of RFP.
RFP has previously been identified as a predictor of morbidity and mortality in acute myocardial infarction patients. 9 However, the majority of these reports, including a meta-analysis from 2008, 10 were performed in the era of thrombolytic therapy where TIMI flow status was not ascertained. Patients were heterogeneous, including both STEMI and non-ST segment elevation myocardial infarction patients. Follow up for the majority was 12-24 months, with only 3/16 studies having longer term follow up (4 years). However, the current study examines the impact of RFP in STEMI patients treated by contemporary PCI therapy, which has significantly improved mortality and LVEF. 11, 12 The definition of RFP has been variable; some defined RFP as E/A ratio >2, while others used a shortened DT. We defined RFP as E/A ratio >2 and/or DT <140 ms in all instances. Although current guidelines for the assessment of LV diastolic function mandates more than E/A ratio and DT, transmitral Doppler is robust for determining RFP and has been used by other investigators, including the MERGE HF group 4 and the European Study Group on Diastolic HF. 13 Despite the modest size of the group and the low number of events, patients with RFP had increased allcause and cardiac death. Multivariate analysis showed stable numeric estimates for both hazards ratios and 95% CIs, with significance consistent with univariate analyses results. A previous study demonstrated that RFP at discharge was an independent predictor of mortality.
14 Therefore, echocardiograms performed immediately post-STEMI may reflect transient LV diastolic dysfunction with subsequent improvement. In this study, as the echocardiograms were performed at variable times (3 days−6 weeks), at worst, we would have underestimated the likely effect of RFP after STEMI.
Approximately 30% of HF patients have preserved LVEF and HF due to DD, 15 with an increasing prevalence with age. 16 While RFP did not predict HF occurrence (Table 2 , P = 0.578), a higher percentage of RFP patients were discharged on diuretics (Table 1) . Cardiac biomarkers (CK, CKMB and TnT) are surrogates of infarct size. [17] [18] [19] Significantly higher CK, CKMB and TnT levels were observed in the RFP group, suggesting that a larger infarct predisposed to the development of RFP. In a multivariate analysis, CK was an independent predictor of RFP, similar to a previous study in STEMI patients that demonstrated a correlation between peak CK and infarct size. 20 There are a several limitations given that this is a single-centre retrospective study with an overall low event rate; nevertheless, we believe our results are clinically important and warrant further study. While the timing of echocardiograms was variable, the percentage of RFP (∼20%) was similar to that reported in other studies. 10 Patients with HT and diabetes may have preexisting DD; however, similar proportions of patients with HT and DM were present in RFP and non-RFP groups. We acknowledge that the modest cohort size increases the likelihood of a type 2 error. However, the weight of previous data on the adverse effects of RFP on cardiac outcomes suggest that this is unlikely.
This study demonstrates that RFP was a determinant of cardiac and all-cause mortality at a median follow up of 5 years post-STEMI treated by PCI. While the evaluation of diastolic function following PCI for STEMI is an evolving area, these preliminary results are interesting but require validation in larger patient cohorts. 
